Spark Biomedical | Daniel Powell, CEO

Spark Biomedical's FDA-cleared Transcutaneous Auricular Neurostimulation (tAN™) is a non-invasive wearable treatment technology for opioid withdrawal relief.
Speakers
Daniel Powell
Daniel Powell
CEO, Spark Biomedical